dark periods without affecting total sleep time or inducing cataplexy, indicating that GABA B receptors are crucial regulators of orexin neurons and that "fine tuning" of orexin neurons by inhibitory and excitatory inputs is important for the stability of sleep/waking states.
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Orexin A and orexin B, also known as hypocretin-1 and hypocretin-2, are critical regulators of sleep/wakefulness states 1 . Orexin neurons are localized exclusively in the lateral hypothalamic area (LHA) and send excitatory projections to the waking-active monoaminergic neurons in the hypothalamus and brainstem regions 1 . The importance of orexins in the maintenance of consolidated sleep/wakefulness states is demonstrated by the fact that the sleep disorder narcolepsy is caused by orexin deficiency in human and animals [2] [3] [4] [5] . Investigations of the efferent and afferent systems of orexin neurons and phenotypic characterization of genetically-modified mice have suggested additional functions for the orexins in the coordination of emotions, energy homeostasis, reward systems, drug addiction, and arousal 1 .
The regulatory mechanisms of orexin neurons are important for understanding the physiological basis of sleep/wake control. In vitro studies showed that the activity of orexin neurons is influenced by several neuropeptides and neurotransmitters 1 . Recent studies showed that orexin neurons receive innervation from several brain regions, including the limbic system (amygdala, bed nucleus of the stria terminalis, and septal regions), preoptic area, and monoaminergic neurons 1, 6 .
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Orexin neurons also receive glutamatergic and GABAergic innervation from local interneurons 1, 7 . In vitro electrophysiological studies showed that both GABA A and GABA B agonists inhibit the activity of orexin neurons [7] [8] [9] , but the physiological relevance of such regulation is unknown.
GABA B receptors (GABA B Rs) are heterodimers composed of GABA B1 and GABA B2 subunits, both of which are required for normal receptor function 10, 11 . GABA B receptors are coupled to G-proteins and modulate synaptic transmission by activating postsynaptic inwardly rectifying Kir3 K + channels (GIRK channels) and by controlling neurotransmitter release through coupling to Ca 2+ channels 12, 13 . Dysfunction of GABA B -mediated synaptic transmission in the central nervous system occurs in several neurological disorders [13] [14] [15] . Among sleep disorders, the partial GABA B R agonist gamma-hydroxybutyrate (GHB) 16 is used to treat both the excessive sleepiness and cataplexy symptoms of human narcolepsy. GABA B R activation inhibits presynaptic release of both glutamate and GABA onto orexin neurons 9 and both pre-and postsynaptic GABA B Rs modulate the activity of orexin neurons 9 .
In the present study, we engineered mice with a selective deletion of the GABA B1 gene in orexin neurons (orexin neuron-restricted knockout mice; GABA B1 -/-(orexin) mice) to study the consequences of the absence of GABA B Rs on orexin neuron function at the cellular and behavioral levels.
Results

Mice Selectively Lacking Functional GABA B Receptors in Orexin Neurons
The GABA B1 subunit is essential for the assembly of functional GABA B receptors and mice lacking the GABA B1 subunit show a complete absence of GABA B responses 17 . To obtain mice with a deletion of the GABA B1 subunit gene restricted to orexin-producing neurons (GABA B1 -/-(orexin) mice), orexin/Cre transgenic mice (see supplementary information) were mated with homozygous floxed GABA B1 mice possessing exon 7 and 8 of the GABA B1 allele flanked by lox-P sites 18 . Double immunofluorescence studies in wild-type control mice showed that many neurons in the LHA had GABA B1 -ir in their soma and dendrites ( Figure 1 ). Among these, many neurons in the LHA were positive for both orexin-ir and GABA B1 -ir ( Figure 1 ). In contrast, neurons positive for both GABA B1 -ir and orexin-ir were rarely detectable in the brain of GABA B1 -/-(orexin) mice, although there were many GABA B1 -ir-positive neurons in the LHA that were negative for orexin ( Figure 1 ). We found that less than 10% of orexin neurons in 
Electrophysiological Characteristics of Orexin Neurons Lacking GABA B Receptors
The electrophysiological properties of orexin neurons were examined in GABA B1 -/-(orexin) mice by patch-clamp recordings using brain slice preparations (Figure 2 ). Bath application of GABA (0. mice. We hypothesized that the activity of local GABAergic neurons expressing the orexin receptor is increased in GABA B1 -/-(orexin) mice due to increased orexin release onto these interneurons. To evaluate this possibility, the orexin receptor antagonist SB334867 was used to block the orexin receptor-1 (OX 1 R). Preincubation with SB334867 (5 μM) reduced the frequency of sIPSCs in orexin neurons of GABA B1 -/-(orexin) mice (basal: 2.7 ± 0.43 Hz, n = 6; SB334867: 1.1 ± 0.30 Hz, n = 7; p= 0.012 by Student t test), but had no effect in control littermate mice (1.1 ± 0.36 Hz, n = 4 vs 1.0 ± 0.13 Hz, n = 9, p= 0.769 by Student t test) (Fig, 3d ). These results indicate that orexin activates local
GABAergic neurons via the OX 1 R resulting in an increase of the GABAergic synaptic input onto orexin neurons, and that activity of these local circuits is increased in GABA B1 -/-(orexin) mice.
Decreased Responsiveness of Orexin Neurons Lacking GABA B Receptors to Excitatory and Inhibitory Inputs
Although the basal membrane potential and firing frequency of orexin neurons in GABA B1 -/-(orexin) mice were comparable to that of wild-type mice due to the compensatory increase in GABAergic input, the absence of GABA B receptors caused abnormalities in these cells. We found that the effect of the 
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-/-(orexin) mice displayed severe fragmentation of sleep/wakefulness states indicated by decreased awake, non-REM, and REM sleep episode durations and reduced REM latency ( Figure   5d and Table 1 ). The fragmentation of sleep/wakefulness states in GABA B1 -/-(orexin) mice was more severe than that previously described in orexin-knockout mice or even in orexin/ataxin-3 transgenic mice in which orexin neurons are specifically ablated 5, 20 . However, neither the direct transitions from an awake state to REM sleep nor the cataplexy-like behavioral arrests that are occasionally observed in both orexin-deficient mice and orexin neuron-ablated mice were observed in
-/-(orexin) mice 5, 20 . Interestingly, in contrast to the findings in orexin-deficient mice in which fragmentation is only observed during the dark period, 5,20 fragmentation of behavioral states in
-/-(orexin) mice occurred during both the light and the dark periods ( Figure 5 and Table 1 ).
Although the total sleep time of GABA B1 -/-(orexin) mice tended to increase when compared to control mice, this difference was not statistically significant ( Figure 5 and Table 1 ). These changes along with a decrease in REM sleep latency indicate increased pressure for entry into REM sleep in
-/-(orexin mice.
Discussion
Orexin neurons are indispensable components of the regulatory mechanism that controls sleep/wake states. We have previously studied the regulatory mechanisms of orexin neurons in vitro 7, 8, [21] [22] [23] [24] . However, the physiological relevance of the regulatory mechanisms or inputs affecting The present experiments showed that typical GABA B responses are almost completely eliminated in orexin neurons from GABA B1 -/-(orexin) mice (Figure 2 ). GABA B agonist-induced postsynaptic effects were also eliminated and the sensitivity of orexin neurons to both GABA A receptor agonists and glutamate was decreased in GABA B1 -/-(orexin) mice ( Figure 4 ). As shown in Figure 3 , we also found that inhibitory synaptic inputs to orexin neurons are increased in
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-/-(orexin) mice. However, in the presence of TTX, mIPSC frequencies are comparable between
-/-(orexin) and control orexin neurons (data not shown). These observations suggest that spontaneous GABA release onto orexin neurons was not increased, but that activity-dependent inhibitory signals from local GABAergic neurons onto orexin neurons were increased in slice preparations from GABA B1 -/-(orexin) mice.
Because deletion of the GABA B R was confined to orexin neurons (Figure 1 ), the increase in GABAergic influence must be attributable to the abnormality of the orexin neurons. We suggest that orexin neurons innervate local GABAergic neurons that, in turn, send inhibitory projections onto the orexin neurons ( Figure 6 ). In the parental GABA B1 floxed line, exons 7 and 8 of GABA B1 gene are flanked by lox-P sites 18 . Therefore, both the GABA B1a and GABA B1b subtypes are deficient in the orexin neurons of the GABA B1 -/-(orexin) mice, which therefore lack functional GABA B receptors altogether. Presumably, in the GABA B1 -/-(orexin) mice, orexin release is increased due to the lack of functional GABA B receptors in the nerve terminal or the somatodendritic compartment of orexin neurons, leading to excessive activation of local GABAergic neurons. Consistent with this hypothesis, preincubation of GABA B1 -/-(orexin) slices with the OX 1 R antagonist reduced the sIPSC frequency to a level similar to that found in control slices (Figure 3d ).
These alterations in the synaptic input of orexin neurons due to a lack of functional GABA B receptors result in severe sleep/waking fragmentation in GABA B1 -/-(orexin) mice during both the light and dark periods ( Figure 5 and Table 1 ), indicating that the GABA B receptor in orexin neurons is indispensable for proper regulation of sleep/wake states. As to why GABA B1 -/-(orexin) mice showed robust fragmentation of sleep/wake behavior in both the dark and light periods, we have previously hypothesized that orexin neurons are appropriately regulated to maintain proper vigilance states according to the animals' environment 1 . In GABA B1 -/-(orexin) mice, the effects of both GABA and glutamate in orexin neurons were severely impaired. Therefore, orexin neurons in these mice are unlikely to be appropriately and tightly regulated (Figure 4 ).
Orexin knockout mice and orexin neuron-deficient mice show behavioral instability and sleep/wake fragmentation only during the dark (active) period 5, 20 . In contrast, transgenic mice with constitutive overexpression of orexin show a fragmented sleep/wake phenotype only during the light (rest) period. The activity of orexin neurons is high during the dark period 29 ; therefore, abnormality of orexin -/-mice during this period might be expected. On the other hand, since the activity of orexin neurons is low or quiescent during the light period, the sleep/wake abnormality of orexin-overexpressing mice becomes apparent during this period 30 . However, GABA B1 -/-(orexin) mice showed robust fragmentation of sleep/wake behavior during both the dark and light periods. In the light (rest) period, orexin neurons might be inhibited by GABAergic influences from GABAergic neurons in the preoptic area 1 , which are likely important for stably silencing orexin neurons 31, 32 . In
-/-(orexin) mice, both GABA A -and GABA B -mediated inhibition of orexin neurons was severely impaired (Figures 2, 3, and 4 ). These defects may explain why these mice showed fragmented sleep in the light period, because orexin neurons in GABA B1 -/-(orexin) mice cannot be effectively inhibited by GABA. On the other hand, during the dark (active) period, orexin neurons would be activated by various excitatory inputs including glutamatergic influences 1 . In GABA B1 -/-(orexin) mice, the effect of glutamate on orexin neurons was also severely impaired ( Figure 4) ; consequently, the activity of orexin neurons is not appropriately regulated to maintain wakefulness according to various inputs ( Figure 6 ).
In GABA B1 -/-(orexin) mice, we did not observe the cataplexy-like behavioral arrests or the direct transitions from wakefulness to REM sleep that are occasionally seen in orexin-deficient animals.
This result is consistent with the observation that mice overexpressing orexin do not show cataplexy, although these mice show fragmentation of sleep/wakefulness states during the light period 30 .
Together, these results suggest that fine tuning of orexinergic tone may not be necessary for inhibition of cataplexy and direct transition from wakefulness to REM sleep. On the other hand, the present study showed that fine tuning of orexin neurons is crucial for stability of sleep/wakefulness states and maintenance of normal sleep/wake architecture (Fig. 5d ).
This study demonstrated the importance of GABA B activity in a defined neuronal circuit and the importance of orexin neuron GABA B Rs for maintenance of wakefulness and sleep state consolidation. The phenotype of GABA B1 -/-(orexin) mice is characterized by impaired ability to maintain any behavioral state, which is one of the primary symptoms of human narcolepsy. Therefore,
-/-(orexin) mice may be a useful model in which to study narcolepsy without cataplexy. Since the partial GABA B agonist GHB is used clinically to extend both sleep bouts and subsequent wakefulness, thereby allowing narcoleptic humans to engage in longer periods of purposeful activity during their waking hours, GABA B1 -/-(orexin) mice may also be a useful model in which to study the therapeutic action of GHB. Impaired ability to maintain wakefulness and consolidate sleep is also one of the hallmarks of sleep in the elderly. Given the widespread use of hypnotic medications that target GABAergic signalling, it will be interesting to determine whether age-related defects in GABAergic control of orexin neurons occur. Lastly, the orexin neurons have been proposed to be a crucial component of a "flip-flop" switch controlling sleep and wakefulness 25 . The orexin system is hypothesized to be the stabilizer of the flip-flop switch 1 . The phenotype of the GABA B1 -/-(orexin) mice suggests that fine regulation of orexin neuronal activity is necessary for proper function of the flip-flop switch.
Methods
Animal Usage
All experimental procedures involving animals were approved by the Animal Experiment and Use
Committee of University of Tsukuba and were in accordance with NIH guidelines.
Generation of Orexin/Cre Transgenic Mice
The transgenic construct was made by substituting the nlacZ gene (SalI-BamHI fragment) of the orexin/nlacZ transgenic construct 33 with the Cre-recombinase cDNA and an internal ribosome entry site with the eGFP (IRES-eGFP) gene (see supplementary information). The transgene was linearized and microinjected into pronuclei of fertilized mouse eggs from the F1 of C57BL/6 x DBA1;
BDF1. Founder animals were bred with C57BL/6 mice to produce a stable orexin/Cre line.
Genotyping of orexin/Cre transgenic mice was performed by PCR of tail DNA. Human prepro-orexin promoter sequences, Cre recombinase, and eGFP coding sequences were amplified with PCR primer sets: human prepro-orexin genomic fragment, sense: GCAGCGGCCATTCCTTGG, anti-sense: AAGTCGACGGTGTCTGGCGCTCAGGGTG; Cre recombinase, sense:
GGTTCGTTCACTCATGGAAAATAG, anti-sense: GGTATCTCTGACCAGAGTCATCCT; eGFP, sense: GAAGGGCATCGACTTCAAGG, anti-sense: ACGAACTCCAGCAGGACCAT.
Breeding and Maintenance of Mouse Lines
Orexin/Cre mice were mated with GABA B1 flox/flox (BALB/cA) mice 18 /J reporter mice (Jackson Laboratories) (Supplementary fig. 1 ).
We produced mice with selective deletion of the GABA B1 gene in orexin neurons by crossing
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flox/flox and orexin/Cre Tg mice. The genetic background of the mice used in this study was a mixture of BALB/c, C57BL/6, and DBA1 (75% : 21.875% : 3.125%). These mice with either a C57BL/6 background or a C57BL/6 and DBA1 mixed background showed similar sleep/wakefulness behavior, consistent with previous studies 34, 35 . The total daily duration of non-REM sleep did not significantly differ between strains, even though the BALB/c strain has been reported to exhibit a shorter period of time in non-REM sleep during the day than the night 36 . These similarities suggest that differences in genetic background have minimal effects on the results of our study. 
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Histological Analysis
Mouse brains were fixed and prepared as previously described 37 . Mice were anesthetized by intraperitoneal injection of sodium pentobarbital and perfused via the heart with phosphate-buffered saline (PBS), followed by 0.1 M phosphate buffer containing 4% paraformaldehyde. The whole brain was postfixed for 2 hr in 4% paraformaldehyde in PBS. Sections were washed with 0.3% Triton X-100 in PBS and incubated with 1% bovine serum albumin in PBS for 1 hr, and then incubated with primary antibodies in the same solution for 1 hr at room temperature. Staining was performed with standard procedures using rabbit or guinea pig anti-orexin antisera 37 , mouse anti-Cre antibody (Nacalai), or guinea pig anti-GABA B1 antibody (Chemicon) and Alexa 488 or 594-conjugated secondary antibodies (Invitrogen). . Pipette resistance was 5-10 MΩ. The series resistance during recording was 10-40 MΩ and was not compensated. The liquid junction potential of the patch pipette solution and perfused HEPES solution was estimated to be 3.9 mV and was applied to the data. The membrane patch was then ruptured by suction, and
EEG/EMG Recording
Drugs
The drugs used were glutamate, GABA, muscimol, baclofen, BIC, PTX, CNQX, 5-HT, and AP5
(Sigma), TTX (Wako), CGP54626 and SB334867 (Tocris), and CCK, orexin A and orexin B (Peptide Institute). Drugs were dissolved in DMSO or the buffers suggested by the suppliers and were diluted with bath HEPES buffer.
Statistical Analysis
Data are presented as mean±SEM and were analyzed by one-way or repeated-measurements 
